It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: jondoeuk
The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer www.ncbi.nlm.nih.gov...
Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer www.ncbi.nlm.nih.gov...
Non-Toxic Metabolic Management of Metastatic Cancer in VM Mice: Novel Combination of Ketogenic Diet, Ketone Supplementation, and Hyperbaric Oxygen Therapy www.ncbi.nlm.nih.gov...
There was a pilot study in 10 advanced cancer patients. The patients did a very low-carb, ketogenic diet for 28 days. According to a PET scan, 4 of the patients continued to have progressive disease, while 5 remained stable and 1 had a partial remission. It could be said that the patients who had the best metabolic response to the diet (that is, lowest insulin and highest ketone levels) saw the most improvement www.ncbi.nlm.nih.gov...
In 1995, a case report of two girls with nonresectable brain cancer (anaplastic astrocytoma stage IV, and cerebellar astrocytoma stage III) was published. After 7 days on a ketogenic diet, blood glucose levels decreased and glucose uptake at tumor site decreased by 21,8%. One of the girls had significant improvement in symptoms and her disease did not progress for the next 12 months, the other was lost to follow up www.ncbi.nlm.nih.gov... One of the patients remains alive at this time (Dr Linda Nebeling MD, personal communication with Prof. Tomas Seyfried PhD)
Rapid Response of Glioblastoma Multiforme with the Ketogenic Diet: A Case Report www.ncbi.nlm.nih.gov...
In a pilot trial of 16 advanced-stage cancer patients, a ketogenic diet did improve quality of life and stopped the progression of cancer for the 5 patients who completed the 12 week study www.ncbi.nlm.nih.gov...
Also I wonder if this diet would help certain immunotherapies www.ncbi.nlm.nih.gov... www.ncbi.nlm.nih.gov... and/or drugs work better?. www.calithera.com... www.cornerstonepharma.com...
originally posted by: PeterMcFly
a reply to: jondoeuk
I almost forgot, don't feed the retard troll infesting this thread...
Groundbreaking new research on the cancer-fighting potential of vitamin C has made the pages of the peer-reviewed journal Science Translational Medicine. A team of researchers from the University of Kansas reportedly tested the effects of vitamin C given in high doses intravenously on a group of human subjects and found that it effectively eradicates cancer cells while leaving healthy cells intact.
“Because vitamin C has no patent potential, its development will not be supported by pharmaceutical companies,” says Qi Chen, lead author of the new study. “We believe that the time has arrived for research agencies to vigorously support thoughtful and meticulous clinical trials with intravenous vitamin C.”
The treatment worked in tandem with standard chemotherapy drugs to slow tumour growth in mouse studies. Meanwhile, a small group of patients reported fewer side-effects when given vitamin C alongside chemotherapy.
So what we have here is a small clinical trial with a 19% dropout rate that wasn’t even blinded. It reported zero difference in overall survival (both were, as one would expect for ovarian cancer at this stage, abysmal), and zero statistically significant difference in time to relapse/progression.